Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sodium valproate for high-risk oral epithelial dysplasia
2018-000197-30Phase 2Unknown
- Sponsor
- University of Liverpool
- Start
- Jun 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of valproic acid in oral dysplasia (OED), sponsored by University of Liverpool. Status: unknown.
02
Drugs
valproic acid
03
Conditions
oral dysplasia (OED)
Beyond the preview
Go deeper on 2018-000197-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-000197-30.